Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-20

Clinical Trial Update: Treatment Use of Generex Oral-lyn™ in Patients With Diabetes

View source ↗

Summary

Clinical trial NCT00948493 evaluating Generex Oral-lyn for diabetes is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral-lyn

Snippet

Sponsor: Generex Biotechnology Corp. | Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | Status: NO_LONGER_AVAILABLE